Literature DB >> 1479623

Inhibition of adenosine metabolism increases myocardial interstitial adenosine concentrations and coronary flow.

S W Ely1, G P Matherne, S D Coleman, R M Berne.   

Abstract

We employed an isolated guinea-pig heart model perfused at constant pressure (70 cmH2O) to test the hypothesis that inhibition of adenosine metabolism increases interstitial adenosine concentrations (as measured with epicardial discs) and coronary flow. Iodotubercidin (ITU, 1 microM) and EHNA (erythro-9-[2-hydroxy-3-nonyl] adenine, 5 microM) were used to inhibit adenosine kinase and deaminase, respectively during control conditions and during metabolic stimulation with 1 microM isoproterenol. The adenosine receptor blocker 8-phenyltheophylline (8-PT) was used during control conditions to assess whether the response seen was adenosine specific. ITU plus EHNA decreased heart rate (202 +/- 10 to 136 +/- 11 beats/min) and increased coronary flow (8.2 +/- 0.3 to 12.4 +/- 0.9 ml/min/g) without a change in MVO2, developed pressure or dP/dt. ITU plus EHNA increased adenosine concentrations in epicardial fluid (0.24 +/- 0.07 microM to 1.02 +/- 0.09 microM) and venous effluent (40 +/- 3 nM to 262 +/- 32 nM) during control conditions, and adenosine release increased from 389 +/- 96 pmols/min/g to 3480 +/- 365 pmols/min/g. 8-PT infusion reversed the effects on heart rate and coronary flow and resulted in a persistent elevation of epicardial fluid adenosine concentrations. During metabolic stimulation with 1 microM isoproterenol, ITU plus EHNA significantly limited the increase in heart rate and ventricular developed pressure and dP/dt while coronary flow increased to a significantly greater extent. Myocardial oxygen consumption was similar during metabolic stimulation between the two groups (vehicle vs. ITU plus EHNA). Epicardial fluid adenosine concentration in the vehicle-treated group increased from 0.17 +/- 0.3 microM to 0.34 +/- 0.02 microM at 15 min of isoproterenol stimulation whereas it increased from 1.10 +/- 0.02 microM to 2.90 +/- 0.46 microM in the ITU plus EHNA-treated group. Inhibition of adenosine metabolism during metabolic stimulation significantly increased venous adenosine concentrations and adenosine release and reduced inosine and hypoxanthine release proportionately. The release of adenosine+inosine+hypoxanthine was unchanged. Inhibition of adenosine metabolism provides evidence supporting the hypothesis that adenosine plays a role in regulating coronary vascular resistance as well as influencing heart rate and ventricular inotropy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1479623     DOI: 10.1016/0022-2828(92)93097-4

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  7 in total

Review 1.  Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.

Authors:  Sean P Colgan; Holger K Eltzschig
Journal:  Annu Rev Physiol       Date:  2011-11-19       Impact factor: 19.318

2.  Sustained adenosine exposure causes lung endothelial barrier dysfunction via nucleoside transporter-mediated signaling.

Authors:  Qing Lu; Julie Newton; Vivian Hsiao; Paul Shamirian; Michael R Blackburn; Mesias Pedroza
Journal:  Am J Respir Cell Mol Biol       Date:  2012-06-28       Impact factor: 6.914

Review 3.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

4.  Specificity of synergistic coronary flow enhancement by adenosine and pulsatile perfusion in the dog.

Authors:  P Pagliaro; H Senzaki; N Paolocci; T Isoda; G Sunagawa; F A Recchia; D A Kass
Journal:  J Physiol       Date:  1999-10-01       Impact factor: 5.182

5.  Insulin restores expression of adenosine kinase in streptozotocin-induced diabetes mellitus rats.

Authors:  Monika Sakowicz; Tadeusz Pawelczyk
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

6.  Machine learning guided association of adverse drug reactions with in vitro target-based pharmacology.

Authors:  Robert Ietswaart; Seda Arat; Amanda X Chen; Saman Farahmand; Bumjun Kim; William DuMouchel; Duncan Armstrong; Alexander Fekete; Jeffrey J Sutherland; Laszlo Urban
Journal:  EBioMedicine       Date:  2020-06-18       Impact factor: 8.143

7.  Effect of diabetes/hyperglycemia on the rat retinal adenosinergic system.

Authors:  Joana Vindeirinho; Gabriel N Costa; Mariana B Correia; Cláudia Cavadas; Paulo F Santos
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.